Healthcare
German health minister’s ‘locust’ sponsor comments spook live healthcare deals – market sources
- New investors scared by minister’s remarks on limiting outpatient profit
- Rush to consolidate and buy ‘plan hospitals’ before any new laws
- Small clinics with succession problems hurry to exit
South Korea’s ramped up FDI regulation hinders Chinese semiconductor and biotechnology M&A attempts
- NASIA strengthens existing FDI regulation of ‘national core technologies’
- Chinese investments in sensitive sectors face deep scrutiny, longer reviews
- Cowin DST suitor Focuslight expects to hear from MOTIE in February
- Ramped up FDI screening comes after government found over 100 tech leakages
- Innovation, price and complaints key factors for Art 22
- Horizon/Amgen bullish on regulatory clearances
- Biologics portfolios cover similar therapeutic areas with no obvious overlaps
Confirm cancellation
Something went wrong.
An error occurred trying to play the stream. Please reload the page and try again.
CloseSign-up to join the ION Analytics Community to:
- Register for events
- Access market insights
- Download reports